A preparation method of Belzutifan and its intermediates

By using mild oxidation reaction in Belzutifan synthesis, the safety and pollution problems of reagents in the prior art were solved, and an efficient and environmentally friendly synthesis route was achieved, which was suitable for industrial production.

CN116178223BActive Publication Date: 2024-12-03SHANGHAI HAOHONG SCI CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202310248582.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2022-04-15
Filing Date
2023-03-15
Publication Date
2024-12-03
Estimated Expiration
2043-03-15

AI Technical Summary

Technical Problem

The existing Belzutifan synthesis method has the disadvantages of reagent safety problems, heavy metal pollution, poor chiral selectivity, long routes, many side reactions, low yields and low atomic utilization, and is difficult to be suitable for industrial production.

Method used

Using a new method with mild reaction conditions, intermediate III compounds were prepared through oxidation reactions, and oxidizing agents such as sodium hypochlorite, tert-butanol peroxide and transition metal compounds such as cuprous chloride were synthesized in one pot method, simplifying the steps and improving the Selectivity and efficiency.

Benefits of technology

It has achieved efficient, environmentally friendly and safe Belzutifan synthesis, and the intermediate III compound has a high atomic utilization, with a yield of more than 95%. It is suitable for industrial production, simplifying the process steps and reducing side reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116178223B_ABST
    Figure CN116178223B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for preparing Belzutifan and an intermediate thereof. The method comprises subjecting a compound of formula IV to an oxidation reaction to prepare an intermediate of formula III. The intermediate of formula III is subjected to a reduction reaction and a fluorination reaction to prepare a compound of formula I, Belzutifan, having the following structural formula: #imgabs0# wherein R1 is selected from hydrogen or an acyl group-C(=O)R2, a silane group, a substituted or unsubstituted C1-C 20 Straight or branched alkyl, sulfonyl-SO2R3 or alkoxycarbonyl-C(=O)-OR4. The method provided by the present invention has short route, high selectivity and simple operation, making it more suitable for developing a green and sustainable Belzutifan production process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of chemical synthesis, and more specifically, relates to a method for chemically synthesizing Belzutifan and intermediates. Background Art

[0002] Belzutifan, developed by Merck, is an EPAS1 inhibitor that was approved by the U.S. Food and Drug Administration (FDA) on August 13, 2021. For the treatment of patients with von Hippel-Lindau (VHL) disease-related cancers, including renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastoma, or pancreatic neuroendocrine tumors (pNET), who do not require immediate surgery.

[0003] Patent (WO2015035223) reports the synthesis method of Belzutifan, and the reaction formula is as follows:

[0004]

[0005] This method has many problems, such as the safety of the reagent high silver chloride used to prepare intermediate 6, heavy metal pollution and poor chiral selectivity. It also has the disadvantages of long route, many side reactions, low yield and low atom utilization.

[0006] Therefore, it is particularly important to develop new synthesis routes and process conditions for Belzutifan that are safer, more environmentally friendly, simpler, more efficient, milder in conditions, lower in cost, and suitable for industrial production. Summary of the invention

[0007] Therefore, in order to overcome the shortcomings of the existing technology, the inventors of the present disclosure have discovered a method for preparing Belzutifan and its intermediates with mild reaction conditions, simple process, good selectivity, higher efficiency, environmental protection and suitability for industrialization through a large number of repeated experiments, and completed the present disclosure on this basis.

[0008] The present invention provides a compound represented by formula III:

[0009]

[0010] wherein R1 is selected from hydrogen or acyl-C(=O)R2, silane, substituted or unsubstituted C1-C 20 Straight or branched alkyl, sulfonyl -SO2R3 or alkoxycarbonyl -C(=O)-OR4;

[0011] wherein R2, R3 or R4 are each independently selected from substituted or unsubstituted C1-C 20Straight chain or branched alkyl, substituted or unsubstituted C3-C 20 Cyclic alkyl, substituted or unsubstituted C2-C 20 Straight chain or branched alkenyl, substituted or unsubstituted C3-C 20 Cyclic alkenyl, substituted or unsubstituted C6-C 20 Aryl; R1 is substituted with C1-C 20 A straight chain or branched alkyl group or R2 is a substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkyl, substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkenyl or substituted C6-C 20 In the case of an aryl group, the substituent is selected from cyano, nitro, amino, hydroxyl, mercapto, halogen, phenyl, halobenzene, nitro-substituted phenyl, C1-C 20 Straight or branched chain, C3-C 20 Cyclic alkyl, C1-C 20 Straight or branched alkenyl, C3-C 20 Cyclic alkenyl, C1-C 20 Straight chain or branched alkoxy, C3-C 20 Cyclic alkoxy;

[0012] In particular, R1 is selected from hydrogen, methyl, ethyl, benzyl, trityl, acetyl, n-propionyl, isopropionyl, n-butyryl, tert-butyryl, benzoyl, p-nitrobenzenesulfonyl, 4-tolyl, fluorophenyl, methanesulfonyl, p-toluenesulfonyl, TBS tert-butyldimethylsilyl, TMS trimethylsilyl, TES triethylsilyl or TBDPS tert-butyldiphenylsilyl; more particularly, R1 is selected from hydrogen, methyl, benzyl, acetyl or TBS tert-butyldimethylsilyl.

[0013] The present invention also provides a method for preparing the compound shown in formula III, the method comprising:

[0014] The reaction is carried out with or without the addition of a transition metal compound, and the compound of formula III is prepared by oxidation reaction of the compound of formula IV with an oxidant.

[0015]

[0016] Wherein, the R1 substituent is defined as above;

[0017] In the preferred technical solution of the present invention, the oxidant is selected from sodium hypochlorite, calcium hypochlorite, tert-butyl peroxide, hydrogen peroxide, sodium peroxide, potassium peroxide, calcium peroxide, peracetic acid, di-tert-butyl peroxide, magnesium peroxide, zinc peroxide, barium peroxide, peroxybenzoic acid, m-chloroperbenzoic acid, urea peroxide, catalase, diisopropyl peroxide, cyclohexanone peroxide, tert-butyl peroxybenzoate, bis(trimethylsilyl)peroxide The invention also comprises one or a mixture of potassium persulfate complex salt, di-tert-butylperoxyisopropylbenzene, nickel peroxide (II) hydrate, diisopropylbenzene hydroperoxide, tetrabutylammonium peroxydisulfate, magnesium monoperoxyphthalate hexahydrate, 1,1-di-tert-butylperoxy-3,3,5-trimethylcyclohexane, 1,1-bis(tert-butylperoxy)cyclohexane, 1,3-bis(tert-butylperoxyisopropyl)benzene or potassium persulfate.

[0018] In the preferred technical solution of the present invention, the molar feed ratio of the oxidant to compound IV is (0.5-8):1, preferably (1-5):1, and more preferably 2:1.

[0019] In the preferred technical scheme of the present invention, the transition metal compound is selected from one or a mixture of cuprous chloride, cuprous bromide, cuprous iodide, cuprous oxide, cuprous cyanide, cuprous acetate, cupric chloride, cupric bromide, cupric oxide, cupric acetate, cupric sulfate, cupric nitrate, ferric chloride, cobalt acetylacetonate, cobalt phosphate, cobalt sulfate, cobalt titanium oxide, cobalt chloride, cobalt tungsten oxide, nano-cobalt ferrite, cobalt trioxide or cobalt acetate.

[0020] In the preferred technical solution of the present invention, the molar feed ratio of the transition metal compound to compound IV is (0.001-0.1):1, preferably (0.001-0.05):1.

[0021] In the preferred technical scheme of the present invention, in particular, the solvent used in the oxidation reaction is selected from water, dioxane, 2-methyltetrahydrofuran, ethylene glycol dimethyl ether, toluene, xylene, chlorobenzene, acetonitrile, acetone, ethanol, isopropanol, n-butanol, tert-butanol, ethylene glycol, pyridine, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide or one or more mixtures of water.

[0022] In a preferred technical solution of the present invention, the volume (mL) of the solvent is 6 to 20 times, preferably 8 to 12 times, the mass (mg) of compound IV.

[0023] In the preferred technical solution of the present invention, the solvent is selected from a mixed solvent of acetonitrile and water, preferably V 乙腈 :V 水 =(1-10):1, more preferably V 乙腈 :V 水=(3-5): 1. In the preferred technical solution of the present invention, in particular, the oxidation reaction is carried out at a reaction temperature of -10-150°C, and more preferably at a reaction temperature of 0-100°C.

[0024] The present invention also provides a method for preparing Belzutifan I, which comprises:

[0025] Method 1:

[0026]

[0027] Wherein R1 is defined as the above-mentioned R1 substituent;

[0028] Step 1: Reducing the compound of formula III with a reducing agent to obtain a compound of formula II;

[0029] Step 2: Fluorination reaction of the compound of formula II with a fluorinated reagent to obtain a compound of formula I;

[0030] Or method 2:

[0031]

[0032] Wherein the R1 substituent is as defined above;

[0033] Step 1: Reducing the compound of formula III with a reducing agent to obtain a compound of formula II;

[0034] Step 2: Fluorination reaction of the compound of formula II with a fluorinated reagent to obtain a compound of formula I;

[0035] Wherein, the compound of formula II is not treated, and step 1 and step 2 are prepared by a one-pot method.

[0036] In the preferred technical scheme of the present invention, in particular, the reducing agent of method one or method two is selected from red aluminum, lithium aluminum tetrahydride, lithium tri-tert-butoxyaluminum hydride, diisobutylaluminum hydride, borane, sodium borohydride, lithium borohydride, potassium borohydride, sodium cyanoborohydride, sodium triethylborohydride, sodium triacetoxyborohydride, sodium trimethoxyborohydride, sodium tri-sec-butylborohydride, sodium tri(1,1,1,3,3,3-hexafluoroisopropoxy)borohydride or a reduction system containing ruthenium catalysis.In the preferred technical solution of the present invention, in particular, the ruthenium-catalyzed reduction system is selected from RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / hydrogen, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / hydrogen, Ruthenium(II)) / formic acid, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))Ruthenium(II)) / ammonium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))Ruthenium(II)) / ammonium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II)) (II)) / sodium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / potassium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / lithium formate , RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / hydrazine hydrate or RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / calcium formate or a mixture of the above.

[0037] In the preferred technical solution of the present invention, the molar feed ratio of the ruthenium catalyst to the compound III is (0.001-0.1):1, preferably (0.001-0.05):1.

[0038] In the preferred technical scheme of the present invention, in particular, the reduction reaction of method one or method two is carried out in a suitable solvent one, and the suitable solvent one is selected from one or a mixture of several of dichloromethane, chloroform, benzene, toluene, xylene, chlorobenzene, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, ethylene glycol dimethyl ether, methyl tert-butyl ether or water.

[0039] According to a preferred technical solution of the present invention, the volume (mL) of the solvent is 1 to 20 times, preferably 5 to 15 times, the mass (mg) of compound III.

[0040] In the preferred technical scheme of the present invention, the fluorination reagent of method one or method two is selected from sulfuryl fluoride, benzenesulfonyl fluoride, trifluoroacetyl fluoride, perfluoroheptanoyl fluoride, perfluorohexanoyl fluoride, nonafluoropentanoyl fluoride, pentafluoropropionyl fluoride, perfluorooctanesulfonyl fluoride, perfluorohexylsulfonyl fluoride, perfluorobutylsulfonyl fluoride, p-toluenesulfonyl fluoride, trifluoromethylsulfonyl fluoride, phenylmethylsulfonyl fluoride, p-nitrobenzenesulfonyl fluoride or 4,6-dimethylpyrimidine-2-sulfonyl fluoride, or a mixture of several thereof.

[0041] In a preferred technical solution of the present invention, the molar feed ratio of the fluorinated reagent to compound II is (1-5):1, preferably (1-3):1.

[0042] In the preferred technical scheme of the present invention, the fluorination reaction of method 1 or method 2 is carried out under the action of a base, wherein the base is selected from 1,8-diazabicyclo[5.4.0]undec-7-ene, ammonium carbonate, lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, ammonium bicarbonate, sodium bicarbonate, potassium bicarbonate, ammonium phosphate, sodium phosphate, potassium phosphate, ammonium monohydrogen phosphate, sodium monohydrogen phosphate, potassium monohydrogen phosphate, lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium carbonate, magnesium hydroxide, calcium carbonate, calcium hydroxide , calcium oxide, magnesium oxide, lithium methoxide, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, lithium isopropoxide, sodium isopropoxide, potassium isopropoxide, lithium tert-butoxide, sodium tert-butoxide, potassium tert-butoxide, magnesium methoxide, magnesium ethoxide, magnesium tert-butoxide, ammonia water, triethylamine, diisopropylamine, diisopropylethylamine, tri-n-butylamine, pyridine, 2-methylpyridine, 2,6-lutidine, 4-dimethylaminopyridine, tetrahydropyrrole, morpholine, piperidine or 2,2,6,6-tetramethylpiperidine or a mixture of one or more thereof.

[0043] In the preferred technical solution of the present invention, the molar feed ratio of the base to compound II is (1-5):1, preferably (1-3):1.

[0044] In the preferred technical scheme of the present invention, in particular, the fluorination reaction of the method one or the method two is carried out in a suitable solvent two, and the suitable solvent two is selected from one or a mixture of dichloromethane, chloroform, benzene, toluene, xylene, chlorobenzene, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, ethylene glycol dimethyl ether, methyl tert-butyl ether, and water;

[0045] In the preferred technical solution of the present invention, the fluorination reaction temperature of the method 1 or the method 2 is -20-20°C, preferably -10-10°C, and more preferably -10-0°C.

[0046] The present invention also provides a method for preparing Belzutifan I, comprising using a compound shown in formula III, wherein the compound of formula III has the following structure:

[0047]

[0048] wherein R1 is selected from hydrogen or acyl-C(=O)R2, silane, substituted or unsubstituted C1-C 20 Straight or branched alkyl, sulfonyl -SO2R3 or alkoxycarbonyl -C(=O)-OR4;

[0049] wherein R2, R3 or R4 are each independently selected from substituted or unsubstituted C1-C 20 Straight chain or branched alkyl, substituted or unsubstituted C3-C 20 Cyclic alkyl, substituted or unsubstituted C2-C 20 Straight chain or branched alkenyl, substituted or unsubstituted C3-C 20 Cyclic alkenyl, substituted or unsubstituted C6-C 20 Aryl; R1 is substituted with C1-C 20 A straight chain or branched alkyl group or R2 is a substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkyl, substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkenyl or substituted C6-C 20 In the case of an aryl group, the substituent is selected from cyano, nitro, amino, hydroxyl, mercapto, halogen, phenyl, halobenzene, nitro-substituted phenyl, C1-C 20 Straight or branched chain, C3-C 20 Cyclic alkyl, C1-C 20 Straight or branched alkenyl, C3-C 20 Cyclic alkenyl, C1-C 20 Straight chain or branched alkoxy, C3-C 20 Cyclic alkoxy;

[0050] In particular, R1 is selected from hydrogen, methyl, ethyl, benzyl, trityl, acetyl, n-propionyl, isopropionyl, n-butyryl, tert-butyryl, benzoyl, p-nitrobenzenesulfonyl, 4-tolyl, fluorophenyl, methanesulfonyl, p-toluenesulfonyl, TBS tert-butyldimethylsilyl, TMS trimethylsilyl, TES triethylsilyl or TBDPS tert-butyldiphenylsilyl; more particularly, R1 is selected from hydrogen, methyl, benzyl, acetyl or TBS tert-butyldimethylsilyl.

[0051] The present invention also provides a method for preparing Belzutifan I, comprising using a compound represented by formula III, wherein the compound represented by formula III is prepared by the following method:

[0052] The compound of formula III is prepared by oxidation reaction of the compound of formula IV with an oxidant with or without adding a transition metal compound, and the compound of formula III is prepared by the above-mentioned method 1 or method 2 to prepare Belzutifan I.

[0053] Beneficial technical effects of the present invention:

[0054] Compared with the prior art, the present invention 1) develops a new intermediate III compound with high atomic utilization, which can efficiently prepare Belzutifan; 2) provides a method for preparing the new intermediate III compound, which can directionally select oxidation sites, has mild reaction conditions, and a yield of more than 95%; 3) utilizes the newly developed intermediate III compound to realize a two-step synthesis to prepare the target product, which is simple and efficient; 4) the newly developed synthesis route can realize one-pot preparation, with simple steps, mild conditions, few side reactions, and a yield of more than 90%, which is safe and environmentally friendly and suitable for development into green and sustainable industrial production. DETAILED DESCRIPTION

[0055] The technical solution of the present invention is described in detail below through specific embodiments, including but not limited to the following embodiments.

[0056] Unless otherwise specified, the reagents and solvents used in the present invention were purchased from commercial sources.

[0057]

[0058] Example 1 Preparation of Compound III-1

[0059] Compound IV-1 (100 g, 0.25 mol) was added to 1200 mL of a mixed solvent of acetonitrile / water (5:1), tert-butyl peroxide (44.2 g, 0.49 mol), copper acetate (450 mg, 0.0023 mol), and heated to reflux for 12 h. The raw material showed that the reaction was complete. The temperature was lowered to 0-10 ° C, 1 L of water was slowly added, stirred for 1 h, and filtered to obtain 100 g of compound III-1, with a yield of 96.7%. LC-MS (ESI) m / z: 444 (M+Na) + .

[0060] 1 H NMR (400MHz, DMSO-d6): δ8.28(dd,4.4Hz,1H),7.90-7.83(m,1H),7.71(d,1H),7.7 1-7.66(m,1H),7.38(t,1H),6.88(d,1H),5.65(dd,1H),3.31(s,3H),2.09(s,3H).

[0061] Example 2 Preparation of Compound III-1

[0062] Compound IV-1 (100 g, 0.25 mol) was added to 900 mL of a mixed solvent of acetonitrile / water (5:1), tert-butyl peroxide (48.2 g, 0.53 mol), ferric chloride (550 mg, 0.0034 mol), and heated under reflux for 12 h. The raw material showed that the reaction was complete, and the temperature was lowered to 0-10 ° C, 1 L of water was slowly added, and stirred for 1 h. Filtered to obtain 97 g of compound III-1, with a yield of 93.8%. LC-MS (ESI) m / z: 444 (M+Na) + .

[0063] Example 3 Preparation of Compound III-1

[0064] Compound IV-1 (100 g, 0.25 mol) was added to 1000 mL of a mixed solvent of acetonitrile / water (4:1), hydrogen peroxide (38.2 g, 1.12 mol), and cuprous iodide (480 mg, 0.0025 mol), and heated under reflux for 12 h. The raw material showed that the reaction was complete, and the temperature was lowered to 0-10 ° C, 1 L of water was slowly added, and stirred for 1 h. Filtered to obtain 98 g of compound III-1, with a yield of 94.8%. LC-MS (ESI) m / z: 444 (M+Na) + .

[0065] Example 4 Preparation of Compound III-1

[0066] Compound IV-1 (100 g, 0.25 mol) was added to 1200 mL of a mixed solvent of acetonitrile / water (5:1), calcium hypochlorite (38.2 g, 0.27 mol), cobalt oxide (480 mg, 0.0064 mol), and heated under reflux for 12 h. The raw material showed that the reaction was complete. The temperature was lowered to 0-10 ° C, 1 L of water was slowly added, stirred for 1 h, and filtered to obtain 90 g of compound III-1, with a yield of 87%. LC-MS (ESI) m / z: 444 (M+Na) +

[0067]

[0068] Example 5 Preparation of Compound III-2

[0069] Compound IV-2 (100 g, 0.21 mol) was added to 1200 mL of a mixed solvent of acetonitrile / water (5:1), tert-butyl peroxide (44.2 g, 0.49 mol), copper acetate (450 mg, 0.0023 mol), and heated under reflux for 12 h. The raw material showed that the reaction was complete, and the temperature was lowered to 0-10 ° C, 1 L of water was slowly added, stirred for 1 h, and filtered to obtain 97 g of compound III-2, with a yield of 94.3%. LC-MS (ESI) m / z: 516 (M+Na) + .

[0070] 1 H NMR (400MHz, DMSO-d6): δ8.25(d,1H),7.84(ddd,1H),7.66(dq,2H),7.29(d,1H) ,6.11(d,1H),5.54(dd,1H),3.30(s,3H),0.80(s,9H),0.16(d,3H),0.15(s,3H).

[0071] Example 6 Preparation of Compound II

[0072] Compound III-1 (500 g, 1.19 mol) was dissolved in 2.5 L of dichloromethane DCM and cooled to 4°C. Formic acid (190 g, 4.13 mol) and Et3N (280 g, 2.77 mol) were added in sequence, and the internal temperature was not higher than 10°C during the addition process. Finally, RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(P-isopropyltoluene)RUTHENIUM(II))ruthenium(II)))(30 g, 0.047 mol) was added, and the reaction solution was reacted at 4°C for 15 h. The reaction solution was slowly dripped into n-heptane (7.5 L) and filtered to obtain 420 g of off-white solid II, with a yield of 92.8%.

[0073] 1 H NMR (500MHz, DMSO-d6): δ7.90(d,1H),7.70(ddd,1H),7.44(dd,J 1H),7.39(dt,1H),7.24(d,1H),5.93(dd,1H),5.84(d,1H),5.60(dt,1H),5.26(ddd,1H),4.91(dt,1H),3.34(s,3H).

[0074] 19 F NMR (471MHz, DMSO-d6): δ107.8 (t, J=9.1Hz), 203.0 (ddd, J=51.3, 14.3, 4.3Hz). HRMS (ESI+): [M+H-H2O] + 364.0457.

[0075] Example 7 Preparation of Compound I

[0076] Compound II (100 g, 0.26 mol) was dissolved in 1 L of ethylene glycol dimethyl ether. Under nitrogen protection, perfluorobutylsulfonyl fluoride (91 g, 0.30 mol) was slowly added dropwise. The reaction temperature was lowered to -10 to 0 °C. 1,8-diazabicyclo[5.4.0]undec-7-ene (44 g, 0.29 mol) was added dropwise. The mixture was moved to room temperature and stirred for 2 h. Water (1 L) was slowly added dropwise to the reaction solution. The mixture was stirred for 10 h and filtered to obtain 95 g of compound I with a yield of 94.5%.

[0077] 1 H NMR(500MHz,acetonitrile-d3)δ8.06(dd,1H),7.44(ddd,1H),7.38~7.34(m,1H),7.26(dt, 1H),7.15(d,1H),5.96(dd,1H),5.73~5.68(m,1H),5.13(ddt,1H),3.95(d,1H),3.25(s,3H). 19 F NMR(564MHz,acetonitrile-d3)δ109.7,184.7(d,J=7.2Hz),214.3(d,J=7.2Hz).HRMS(ESI-TOF)m / z:[MH] - 382.0361.

[0078] The above description is only a preferred specific implementation of the present invention, but the protection scope of the present invention is not limited thereto;

[0079] Any technician familiar with the technical field can make equivalent substitutions or changes according to the technical solution and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A method for preparing a compound shown in formula III, the method comprising: The reaction is carried out with or without the addition of a transition metal compound, and the compound of formula III is prepared by oxidation reaction of the compound of formula IV with an oxidant. wherein R1 is selected from hydrogen or acyl-C(=O)R2, silane, substituted or unsubstituted C1-C 20 Straight or branched alkyl, sulfonyl -SO2R3 or alkoxycarbonyl -C(=O)-OR4; wherein R2, R3 or R4 are each independently selected from substituted or unsubstituted C1-C 20 Straight chain or branched alkyl, substituted or unsubstituted C3-C 20 Cyclic alkyl, substituted or unsubstituted C2-C 20 Straight chain or branched alkenyl, substituted or unsubstituted C3-C 20 Cyclic alkenyl, substituted or unsubstituted C6-C 20 Aryl; R1 is substituted with C1-C 20 A straight chain or branched alkyl group or R2 is a substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkyl, substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkenyl or substituted C6-C 20 In the case of an aryl group, the substituent is selected from cyano, nitro, amino, hydroxyl, mercapto, halogen, phenyl, halobenzene, nitro-substituted phenyl, C1-C 20 Straight or branched chain, C3-C 20 Cyclic alkyl, C1-C 20 Straight or branched alkenyl, C3-C 20 Cyclic alkenyl, C1-C 20 Straight chain or branched alkoxy, C3-C 20 Cyclic alkoxy.

2. The method according to claim 1, characterized in that: The R1 is selected from hydrogen, methyl, ethyl, benzyl, trityl, acetyl, n-propionyl, isopropionyl, n-butyryl, tert-butyryl, benzoyl, p-nitrobenzenesulfonyl, 4-Tolyl, fluorophenyl, methanesulfonyl, p-toluenesulfonyl, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl or tert-butyldiphenylsilyl.

3. The method according to claim 1, characterized in that: The R1 is selected from hydrogen, methyl, benzyl, acetyl or tert-butyldimethylsilyl.

4. The method according to claim 1, characterized in that: The oxidant is selected from sodium hypochlorite, calcium hypochlorite, tert-butyl peroxide, hydrogen peroxide, sodium peroxide, potassium peroxide, calcium peroxide, peracetic acid, di-tert-butyl peroxide, magnesium peroxide, zinc peroxide, barium peroxide, peroxybenzoic acid, m-chloroperbenzoic acid, urea peroxide, catalase, diisopropyl peroxide, cyclohexanone peroxide, tert-butyl perbenzoate, bis(trimethylsilyl)peroxide, potassium persulfate complex salt, di-tert-butyl peroxyisopropyl benzene, nickel peroxide (II) hydrate, diisopropyl hydroperoxide, tetrabutylammonium peroxydisulfate, magnesium monoperoxyphthalate hexahydrate, 1,1-di-tert-butyl peroxy-3,3,5-trimethylcyclohexane, 1,1-bis(tert-butylperoxy)cyclohexane, 1,3-bis(tert-butylperoxyisopropyl)benzene or potassium persulfate, or a mixture of several thereof.

5. The method according to any one of claims 1 to 4, characterized in that: The transition metal compound is selected from cuprous chloride, cuprous bromide, cuprous iodide, cuprous oxide, cuprous cyanide, cuprous acetate, cupric chloride, cupric bromide, cupric oxide, cupric acetate, cupric sulfate, cupric nitrate, ferric chloride, cobalt acetylacetonate, cobalt phosphate, cobalt sulfate, cobalt titanium oxide, cobalt chloride, cobalt tungsten oxide, nano-cobalt ferrite, cobalt trioxide or cobalt acetate, or a mixture of several thereof.

6. The method according to any one of claims 1 to 4, characterized in that: The solvent used in the oxidation reaction is selected from water, dioxane, 2-methyltetrahydrofuran, ethylene glycol dimethyl ether, toluene, xylene, chlorobenzene, acetonitrile, acetone, ethanol, isopropanol, n-butanol, tert-butanol, ethylene glycol, pyridine, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide or one or a mixture of several of them in water.

7. The method according to any one of claims 1 to 4, characterized in that: The oxidation reaction is carried out at a reaction temperature of -10 to 150°C.

8. The method according to any one of claims 1 to 4, characterized in that: The molar ratio of the compound of formula IV to the oxidant is 1:(0.5-8).

9. The method according to claim 7, characterized in that: The reaction temperature is 0-100°C.

10. The method according to claim 8, characterized in that: The molar ratio of the compound of formula IV to the oxidant is 1: (1~5)。 11. A method for preparing Belzutifan Formula I, characterized in that The method includes: Method 1: wherein the R1 substituent is defined as R1 in claim 1; Step 1: Reducing the compound of formula III with a reducing agent to obtain a compound of formula II; Step 2: Fluorination reaction of the compound of formula II with a fluorinating agent to obtain a compound of formula I; Or method 2: wherein the R1 substituent is defined as R1 in claim 1; Step 1: Reducing the compound of formula III with a reducing agent to obtain a compound of formula II; Step 2: Without treatment, the compound of formula II is reacted with a fluorination agent to obtain a compound of formula I; Wherein, the compound of formula II is not treated, and step 1 and step 2 are prepared by a one-pot method.

12. The method according to claim 11, characterized in that: The reducing agent of method one or method two is selected from red aluminum, lithium aluminum tetrahydride, lithium tri-tert-butoxyaluminum hydride, diisobutylaluminum hydride, borane, sodium borohydride, lithium borohydride, potassium borohydride, sodium cyanoborohydride, sodium triethylborohydride, sodium triacetoxyborohydride, sodium trimethoxyborohydride, sodium tri-sec-butylborohydride, sodium tri(1,1,1,3,3,3-hexafluoroisopropoxy)borohydride or a reduction system containing ruthenium catalysis.

13. The method according to claim 12, characterized in that The ruthenium-catalyzed reduction system is selected from RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))Ruthenium(II)) / Hydrogen, RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))Ruthenium(II)) / Hydrogen, {[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / formic acid, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / ammonium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(P-isopropyltoluene)RUTHENIUM(II))Ruthenium(II)) / sodium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(P- Cymene)RUTHENIUM(II))Ruthenium(II)) / potassium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-cymene)RUTHENIUM(II))Ruthenium(II)) / lithium formate, RuCl(p-cymene)[(R,R)-Ts-DPEN](chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino} [(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / hydrazine hydrate or RuCl(p-cymene)[(R,R)-Ts-DPEN](Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amino}(p-isopropyltoluene)RUTHENIUM(II))ruthenium(II)) / calcium formate or a mixture of the above.

14. The method according to claim 11, characterized in that: The reduction reaction of method one or method two is carried out in a suitable solvent one, and the suitable solvent one is selected from one or a mixture of dichloromethane, chloroform, benzene, toluene, xylene, chlorobenzene, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, ethylene glycol dimethyl ether, methyl tert-butyl ether or water.

15. The method according to claim 11, characterized in that The fluorination reagent of method one or method two is selected from sulfuryl fluoride, benzenesulfonyl fluoride, trifluoroacetyl fluoride, perfluoroheptanoyl fluoride, perfluorohexanoyl fluoride, nonafluoropentanoyl fluoride, pentafluoropropionyl fluoride, perfluorooctanesulfonyl fluoride, perfluorohexylsulfonyl fluoride, perfluorobutylsulfonyl fluoride, p-toluenesulfonyl fluoride, trifluoromethylsulfonyl fluoride, phenylmethylsulfonyl fluoride, p-nitrobenzenemethylsulfonyl fluoride or 4,6-dimethylpyrimidine-2-sulfonyl fluoride, or a mixture of several thereof.

16. The method according to claim 11, characterized in that: The fluorination reaction of the method 1 or the method 2 is carried out under the action of a base.

17. The method according to claim 16, characterized in that: The base is selected from 1,8-diazabicyclo[5.4.0]undec-7-ene, ammonium carbonate, lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, ammonium bicarbonate, sodium bicarbonate, potassium bicarbonate, ammonium phosphate, sodium phosphate, potassium phosphate, ammonium monohydrogen phosphate, sodium monohydrogen phosphate, potassium monohydrogen phosphate, lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium carbonate, magnesium hydroxide, calcium carbonate, calcium hydroxide, calcium oxide, magnesium oxide, lithium methoxide, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, lithium isopropoxide, sodium isopropoxide, potassium isopropoxide, lithium tert-butoxide, sodium tert-butoxide, potassium tert-butoxide, magnesium methoxide, magnesium ethoxide, magnesium tert-butoxide, ammonia water, triethylamine, diisopropylamine, diisopropylethylamine, tri-n-butylamine, pyridine, 2-methylpyridine, 2,6-lutidine, 4-dimethylaminopyridine, tetrahydropyrrole, morpholine, piperidine or 2,2,6,6-tetramethylpiperidine, one or a mixture of several thereof.

18. The method according to claim 11, characterized in that: The fluorination reaction of method one or method two is carried out in a suitable solvent two, and the suitable solvent two is selected from one or a mixture of dichloromethane, chloroform, benzene, toluene, xylene, chlorobenzene, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, ethylene glycol dimethyl ether, methyl tert-butyl ether, and water.

19. A compound represented by formula III: in, R1 is selected from hydrogen or acyl-C(=O)R2, silane, substituted or unsubstituted C1-C 20 Straight or branched alkyl, sulfonyl -SO2R3 or alkoxycarbonyl -C(=O)-OR4; wherein R2, R3 or R4 are each independently selected from substituted or unsubstituted C1-C 20 Straight chain or branched alkyl, substituted or unsubstituted C3-C 20 Cyclic alkyl, substituted or unsubstituted C2-C 20 Straight chain or branched alkenyl, substituted or unsubstituted C3-C 20 Cyclic alkenyl, substituted or unsubstituted C6-C 20 Aryl; R1 is substituted with C1-C 20 A straight chain or branched alkyl group or R2 is a substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkyl, substituted C1-C 20 Straight or branched chain, substituted C3-C 20 Cyclic alkenyl or substituted C6-C 20 In the case of an aryl group, the substituent is selected from cyano, nitro, amino, hydroxyl, mercapto, halogen, phenyl, halobenzene, nitro-substituted phenyl, C1-C 20 Straight or branched chain, C3-C 20 Cyclic alkyl, C1-C 20 Straight or branched alkenyl, C3-C 20 Cyclic alkenyl, C1-C 20 Straight chain or branched alkoxy, C3-C 20 Cyclic alkoxy.

20. The compound of formula III according to claim 19, characterized in that: The R1 is selected from hydrogen, methyl, ethyl, benzyl, trityl, acetyl, n-propionyl, isopropionyl, n-butyryl, tert-butyryl, benzoyl, p-nitrobenzenesulfonyl, 4-tolyl, fluorophenyl, methanesulfonyl, p-toluenesulfonyl, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl or tert-butyldiphenylsilyl.

21. The compound of formula III according to claim 19 or 20, characterized in that: The R1 is selected from hydrogen, methyl, benzyl, acetyl or tert-butyldimethylsilyl.

22. A method for preparing Belzutifan Formula I, comprising the method for preparing the compound of Formula III according to claim 1 or 2 or the method for preparing Belzutifan Formula I from the compound of Formula III according to claim 19.

Citation Information

Patent Citations

  • Aryl ethers and uses thereof

    WO2015035223A1

  • Aryl ethers and uses thereof

    CN110372550A

  • Tri-fused ring compound as well as preparation method and application thereof

    CN114315552A

  • Methods of preparing substituted indanes

    US20220081407A1

  • Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof

    WO2017053192A1